CL
Climb Bio, Inc. (CLYM)
NASDAQ·Healthcare·Biotechnology
$12.44
-12.46%
Mkt Cap $804.54M
Analyst Ratings
Buy
18
Hold
0
Sell
0
Price Target (10 analysts)
$21.67
Range $17.00 – $35.00
Implied Upside
+74.3%
Consensus $21.67 vs current $12.44
NASDAQ·Healthcare·Biotechnology
$12.44
-12.46%
Mkt Cap $804.54M
Buy
18
Hold
0
Sell
0
Price Target (10 analysts)
$21.67
Range $17.00 – $35.00
+74.3%
Consensus $21.67 vs current $12.44